Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)

Authors:

Abstract
Introduction: Measurable residual disease (MRD) detected by multiparameter flow cytometry (MFC) played a key role in monitoring therapeutic efficacy and predict